Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaun P Forbes

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of General Internal Medicine|March 21, 2020
Benchmarking Observational Analyses Against Randomized Trials: a Review of Studies Assessing Propensity Score MethodsShaun P Forbes, Issa J Dahabreh
The Journal of the American Academy of Orthopaedic Surgeons|June 14, 2021
Bounding the Implications of Noncompliance in Randomized Controlled Trials in Orthopaedics: An Example in Arthroscopic SurgeryShaun P Forbes, Roy K Aaron, Thomas A Trikalinos
Journal of Managed Care & Specialty Pharmacy|July 1, 2024
Real-world clinical and economic outcomes for patients with advanced non-small cell lung cancer enrolled in a clinical trial following comprehensive genomic profiling via liquid biopsyJulie A Wiedower, Shaun P Forbes, L Jill Tsai, et al.
Journal of Medical Economics|January 24, 2020
Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia AKeziah Cook, Shaun P Forbes, Kelly Adamski, et al.
Journal of Medical Economics|February 28, 2026
Impact of offering blood-based testing alongside existing modalities for colorectal cancer screening among those who previously declined screening: an economic evaluationShaun P Forbes, Elifnur Yay Donderici, Nicole Zhang, et al.
Gastroenterology|July 31, 2025
Colonoscopic Follow-Up After Abnormal Blood-Based Colorectal Cancer Screening ResultsTimothy A Zaki, Nicole J Zhang, Shaun P Forbes, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2024
Associations Among Optimal Lung Cancer Treatment, Clinical Outcomes, and Health Care Utilization in Patients Who Underwent Comprehensive Genomic ProfilingAdam C Powell, Elifnur Yay Donderici, Nicole J Zhang, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 3, 2025
Cost-effectiveness of blood-based colorectal cancer screening - a simulation model incorporating real-world longitudinal adherenceElifnur Yay Donderici, Shaun P Forbes, Nicole J Zhang, et al.
Plos Neglected Tropical Diseases|July 11, 2023
Socio-economic and environmental factors associated with high lymphatic filariasis morbidity prevalence distribution in BangladeshTijana Williams, Mohammad Jahirul Karim, Shihab Uddin, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 16, 2022
Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or StrokeAnna Narezkina, Nausheen Akhter, Xiaoxiao Lu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of General Internal Medicine|March 21, 2020
Benchmarking Observational Analyses Against Randomized Trials: a Review of Studies Assessing Propensity Score MethodsShaun P Forbes, Issa J Dahabreh
The Journal of the American Academy of Orthopaedic Surgeons|June 14, 2021
Bounding the Implications of Noncompliance in Randomized Controlled Trials in Orthopaedics: An Example in Arthroscopic SurgeryShaun P Forbes, Roy K Aaron, Thomas A Trikalinos
Journal of Managed Care & Specialty Pharmacy|July 1, 2024
Real-world clinical and economic outcomes for patients with advanced non-small cell lung cancer enrolled in a clinical trial following comprehensive genomic profiling via liquid biopsyJulie A Wiedower, Shaun P Forbes, L Jill Tsai, et al.
Journal of Medical Economics|January 24, 2020
Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia AKeziah Cook, Shaun P Forbes, Kelly Adamski, et al.
Journal of Medical Economics|February 28, 2026
Impact of offering blood-based testing alongside existing modalities for colorectal cancer screening among those who previously declined screening: an economic evaluationShaun P Forbes, Elifnur Yay Donderici, Nicole Zhang, et al.
Gastroenterology|July 31, 2025
Colonoscopic Follow-Up After Abnormal Blood-Based Colorectal Cancer Screening ResultsTimothy A Zaki, Nicole J Zhang, Shaun P Forbes, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2024
Associations Among Optimal Lung Cancer Treatment, Clinical Outcomes, and Health Care Utilization in Patients Who Underwent Comprehensive Genomic ProfilingAdam C Powell, Elifnur Yay Donderici, Nicole J Zhang, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 3, 2025
Cost-effectiveness of blood-based colorectal cancer screening - a simulation model incorporating real-world longitudinal adherenceElifnur Yay Donderici, Shaun P Forbes, Nicole J Zhang, et al.
Plos Neglected Tropical Diseases|July 11, 2023
Socio-economic and environmental factors associated with high lymphatic filariasis morbidity prevalence distribution in BangladeshTijana Williams, Mohammad Jahirul Karim, Shihab Uddin, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 16, 2022
Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or StrokeAnna Narezkina, Nausheen Akhter, Xiaoxiao Lu, et al.
Pageof 2